Central Alerting System
View Alert


Originator: MHRA Drug Alerts

From: Alison Bunce - Medicines and Healthcare Products Regulatory Agency

Issue date: 04-Apr-2019 14:00:10

This alert has been issued to:
  • MHRA (Medicines) Drug Alerts (Various Recipients)
  • NHS Regional Offices
  • NHS Foundation Trusts (England) - Medical Director
  • NHS Trusts (England) - Medical Director
  • Territorial CMOs in Northern Ireland, Scotland & Wales
  • Regional Directors of Public Health

  • Clinical Commissioning Groups
  • NHS Foundation Trusts (England) - Chief Executive
  • MHRA (Medicines) Drug Alerts - Non-NHS Recipients
  • Director of Public Health
  • NHS Trusts (England) - Chief Executive

Action category: Class 4: For information

Title: DRUG ALERT CLASS 4, FOR INFORMATION, SUN PHARMACEUTICAL INDUSTRIES EUROPE BV, ZOLEDRONIC ACID 5MG SOLUTION FOR INFUSION

Broadcast content: Some units from one particular batch contain the wrong Patient Information Leaflet.

Full details of the drug alert are included in the attached PDF file. Please forward to listed recipients. This information is also published on the MHRA websitehttps://www.gov.uk/drug-device-alerts 

We understand that this product is used in hospitals and is unlikely to be used in General Practice or Community Pharmacy. Please do not send  this communication to Community Pharmacists or to GPs unless they are known to use the product outside the hospital setting. 



Alert reference: EL (19)A/08

Attachments:
Cascade to:
  • #HospitalPharmacy#


Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency